Indivior Pharmaceuticals, Inc. (INDV)
35.71
+0.33
(+0.93%)
USD |
NASDAQ |
Oct 02, 16:00
35.35
-0.36
(-1.01%)
After-Hours: 20:00
Indivior Pharmaceuticals Profit Margin (Quarterly) : 35.57% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 35.57% |
| March 31, 2026 | 28.08% |
| December 31, 2025 | 28.49% |
| September 30, 2025 | 13.38% |
| June 30, 2025 | 5.96% |
| March 31, 2025 | 17.67% |
| December 31, 2024 | 7.05% |
| September 30, 2024 | 7.17% |
| June 30, 2024 | -32.44% |
| March 31, 2024 | 21.48% |
| December 31, 2023 | 18.43% |
| September 30, 2023 | -49.82% |
| June 30, 2023 | 14.13% |
| March 31, 2023 | 17.39% |
| December 31, 2022 | -75.62% |
| September 30, 2022 | 17.67% |
| June 30, 2022 | 21.72% |
| March 31, 2022 | 19.81% |
| December 31, 2021 | 15.77% |
| September 30, 2021 | 14.44% |
| June 30, 2021 | 30.85% |
| March 31, 2021 | 44.44% |
| December 31, 2020 | -7.03% |
| Date | Value |
|---|---|
| September 30, 2020 | 6.29% |
| June 30, 2020 | 12.00% |
| March 31, 2020 | -106.5% |
| December 31, 2019 | -41.35% |
| September 30, 2019 | 24.12% |
| June 30, 2019 | 34.88% |
| March 31, 2019 | 27.73% |
| December 31, 2018 | 10.17% |
| September 30, 2018 | 36.33% |
| June 30, 2018 | 26.12% |
| March 31, 2018 | 36.47% |
| December 31, 2017 | -54.72% |
| September 30, 2017 | 18.18% |
| June 30, 2017 | 25.35% |
| March 31, 2017 | 30.19% |
| December 31, 2016 | 30.12% |
| September 30, 2016 | -55.60% |
| June 30, 2016 | 20.80% |
| March 31, 2016 | 19.38% |
| December 31, 2015 | 14.92% |
| September 30, 2015 | 19.28% |
| June 30, 2015 | 24.81% |
| March 31, 2015 | 30.68% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Supernus Pharmaceuticals, Inc. | -26.65% |
| Eli Lilly & Co. | 30.88% |
| Bristol Myers Squibb Co. | 25.54% |
| Liquidia Corp. | 43.52% |
| Harmony Biosciences Holdings, Inc. | 28.87% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | 27.30% |
| Return on Invested Capital | 150.8% |
| Gross Profit Margin (Quarterly) | 85.42% |
| Operating Margin (Quarterly) | 48.10% |
| Return on Net Operating Assets | 58.33% |